Q65) Identify the correct code below with the statements given above.
(A) Union Government decided to defer the proposed talks between the Chief negotiators on India–European Union (EU) Broad based Investment and Trade Agreement (EU-BTIA) for the present
(R) This decision was taken as the Union Government was disappointed and concerned by the action of EU in imposing legally binding ban on the sale of around 700 pharma products clinically tested by GVK Biosciences, Hyderabad
Q65) Identify the correct code below with the statements given above.
(A) Union Government decided to defer the proposed talks between the Chief negotiators on India–European Union (EU) Broad based Investment and Trade Agreement (EU-BTIA) for the present
(R) This decision was taken as the Union Government was disappointed and concerned by the action of EU in imposing legally binding ban on the sale of around 700 pharma products clinically tested by GVK Biosciences, Hyderabad
The correct option is A If both A and R are correct and R correctly explains A
Ans:65)(a)Extra information-The Government was engaged on the issue with various EU regulators over long period
Pharmaceutical industry is one of the flagship sectors of India which has developed its reputation through strong research and safety protocols over the years. Therefore, Union Government will examine all options in this regard. It is pertinent to mention that most of these drugs are already in EU market for many years without any adverse pharmaco-vigilance report from any member state.
Chief negotiators of India and the EU were scheduled to resume the negotiations on the proposed free trade agreement to boost two-way commerce and investment, after a gap of two years, on the Broadbased Investment and Trade Agreement (BTIA) on 28 August 2015.
If both A and R are correct and R correctly explains A
Ans:65)(a)Extra information-The Government was engaged on the issue with various EU regulators over long period
Pharmaceutical industry is one of the flagship sectors of India which has developed its reputation through strong research and safety protocols over the years. Therefore, Union Government will examine all options in this regard. It is pertinent to mention that most of these drugs are already in EU market for many years without any adverse pharmaco-vigilance report from any member state.
Chief negotiators of India and the EU were scheduled to resume the negotiations on the proposed free trade agreement to boost two-way commerce and investment, after a gap of two years, on the Broadbased Investment and Trade Agreement (BTIA) on 28 August 2015.
